Kexing Biopharm Co., Ltd.SSE: 688136

Report for Q3 2025

· Issued by Kexing Biopharm Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 12 pages · Chinese

Kexing Biopharm Co., Ltd. on 6ix

Earlier from Kexing Biopharm

Later from Kexing Biopharm

All Kexing Biopharm news releases